CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Cellvax's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 28, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 26, 2024Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes1

Top competitors of Cellvax

Top competitors of Cellvax based on patent oppositions.